Sixteen big drug companies made deals with the Trump administration to lower drug prices. But in January, all of them raised prices on some of their drugs. These deals were supposed to help Americans pay less for medicine and make other rich countries pay more. But according to a new report, these c
Merck, a big name in vaccines, recently spoke up about changes to the U. S. vaccine schedule for kids. They believe any changes should be based on solid science and expert advice. The CDC and other health groups recently moved some vaccines, like those for rotavirus and flu, to a category where pare
Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi
The stock market had a wild ride recently, with some companies seeing huge gains while others took a big hit. Let's break it down. Zenas BioPharma, a biotech company, saw its stock drop by more than half after their new drug showed promise in trials. The drug, obexelimab, is meant to treat a rare d
A new drug called retatrutide has shown some amazing results in a recent trial. People who took it lost a lot of weight and felt less pain in their knees. This drug is made by a company called Eli Lilly, which already has other popular drugs for weight loss and diabetes. The trial lasted about a ye
The hunt for new cancer treatments is tough and pricey. But what if we could use old drugs in new ways? That's where machine learning (ML) comes in. It's a type of smart tech that can spot patterns and make predictions. Researchers are using it to find new uses for existing drugs. This could save ti
Huntsville, Alabama, is about to get a major boost. Eli Lilly, a big name in the pharmaceutical world, is putting $6 billion into a new facility there. This isn't just any old factory; it's a high-tech hub for making advanced medicines. The focus will be on small molecule synthetic and peptide medic
Gannet BioChem, a top player in the specialty chemical industry, has just hit a major milestone. They've got the green light from the Science Based Targets initiative (SBTi) for their plans to cut down on greenhouse gas emissions. This isn't just any old goal-setting; it's a big deal in the world of
In the world of science, there are many unsung heroes. One such hero is a person who worked in the pharmaceutical industry. Their job was to protect science from harmful policies. But their life changed when they faced a serious health issue. It all began with a bad backache. They ignored it at fir
Semaglutide, the star ingredient in weight-loss drugs Ozempic and Wegovy, just took a big hit. Two major trials showed it doesn't help people with early Alzheimer's or mild memory issues. Thousands of people aged 55 to 85 took part, but the results were clear: no improvement in memory or daily funct
